Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Satoshi Ichikawa being referenced
Phase I study of tirabrutinib (ONO ‐4059/GS ‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan
2019
Association between BACH 2 expression and clinical prognosis in diffuse large B‐cell lymphoma
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Satoshi Ichikawa | 134 | 119 | 108 | 71 | 426 | |
| Mohamed Mabed | 104 | 61 | 62 | 37 | 384 | |
| In Keun Choi | 95 | 76 | 55 | 36 | 417 | |
| Daisuke Miura | 159 | 79 | 137 | 59 | 453 | |
| Timuçin Çil | 163 | 86 | 70 | 53 | 448 | |
| Horia Bumbea | 212 | 131 | 99 | 64 | 418 | |
| Nishant Tageja | 206 | 112 | 75 | 33 | 502 | |
| Siba El Hussein | 112 | 98 | 163 | 66 | 466 | |
| Umut Dişel | 107 | 54 | 53 | 46 | 459 | |
| Hiroaki Shimizu | 141 | 43 | 62 | 45 | 496 | |
| Y Pawlotsky | 156 | 112 | 48 | 50 | 465 |
All Works
Login with ORCID to disown or claim papers
Loading papers...